AI Summary & Key Takeaways
AI InsightConclusion: As a result of findings in this study indicate that It was determined that the risk of DM was high in the first degree relatives of the patients hospitalized with Type-2 DM and the FINDRISK score scale was a good scale in predicting new asymptomatic Type 2 diabetes.
📌 3 Key Takeaways
Abstract
Objective: This study was conducted to evaluate the diabetes risk in first degree relatives of Type-2 diabetic patients who were not diagnosed with diabetes and test the validity of the Finnish Diabetes Risk Score (FINDRISK) in determining the risk of type-2 diabetes. Methods: First degree relatives of patients who were hospitalized in “İzmir Katip Çelebi University Atatürk Training and Research Hospital”, who were not diagnosed with diabetes before, were included in this cross-sectional study. The sample of the research consisted of 200 people determined by power analysis. Data were collected by “a structured question form” and the FINRISK scale. Participants’ height, weight, waist circumference were measured by the researcher, and venous fasting blood glucose (FBG) with Glycosylated Hemoglobin (HbA1c) were taken by the researcher. Results: The average age of the participants was 46.93 ± 14.83 (18-86). It was determined that the vast majority of the individuals participating in the study were female (65%), 63% were married, 50.5% received high school or higher education, and 59% worked in an income-generating job. The findings was indicated that 41.5% of the participants were in the ‘high-risk group’ for type-2 diabetes according to the FINDRISK score scale. Sensitivity of FINDRISK score to FBG was 100% and specificity was 60%. Conclusion: As a result of findings in this study indicate that It was determined that the risk of DM was high in the first degree relatives of the patients hospitalized with Type-2 DM and the FINDRISK score scale was a good scale in predicting new asymptomatic Type 2 diabetes.